Acquisition Opportunity VPMR was acquired by Danforth Advisors in December 2024, suggesting a potential consolidation of market research capabilities for life sciences portfolios and possible integration projects or post-acquisition service expansions to leverage Danforth’s client base.

Life Sciences Focus Specialization in pharmaceutical and healthcare market research across the product lifecycle positions VPMR to upsell broader longitudinal studies, forecasting, and post-launch analytics to pharma/biotech clients pursuing new product development and lifecycle management.

Global Custom Capabilities Full-service, global, custom primary research with both qualitative and quantitative methods enables tailored studies for physicians and healthcare stakeholders, offering opportunities to propose integrated research solutions combining primary and secondary data.

Growth Through Data Integration Experience integrating primary and secondary data to target physicians and construct forecast models creates a sales angle for clients seeking enhanced targeting, payer considerations, and data-driven decision support.

SMB to Mid-Market Potential With 11-50 employees and revenue in the 10-25 million range, VPMR fits mid-market pharma and healthcare brands looking for flexible, high-touch research partners, suggesting opportunities for accelerator programs, retainer-based engagements, and scalable research bundles.